Finally, we determinedthe on-cell HER2 interactome using the different Fab-catalysts boundto HER2 on SKBR3 cells.36 SKBR3 cells area well-known breast cancer cell line that overexpresses HER2 leadingto constitutive oncogenic activation (Figure 1C). This evidence concerns the gene ERBB2 and breast carcinoma.